Roycederm Stye Relief Eye Spray. Spray
NDC Package 85424-006-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Roycederm Stye Relief Eye Spray. (hypochlorous acid) sprays is spray directly onto closed eyelids or applyusing a sterile cotton padGently wipe acrossthe eyelid and lash lineUse 1-2 times daily oras recommended by your eye care professionalIf you wear contact lenses, please removethem before useFor external eyelid use only. This formulation utilizes a spray delivery system. Marketed by Roycederm Llc, this product is identified by NDC 85424-006 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
85424-006-01
Package Description
100 g in 1 BOTTLE, SPRAY
Product Code
85424-006
11-Digit Billing Format
85424000601
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Roycederm Stye Relief Eye Spray.
Non-Proprietary Name
Hypochlorous Acid
Substance Name
Hypochlorous Acid
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
HYPOCHLOROUS ACID .01 g/100g
Usage Information
Spray directly onto closed eyelids or applyusing a sterile cotton padGently wipe acrossthe eyelid and lash lineUse 1-2 times daily oras recommended by your eye care professionalIf you wear contact lenses, please removethem before useFor external eyelid use only

Regulatory & Marketing

Labeler Name
Roycederm Llc
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-12-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85424-006-01 identifies a specific commercial package of 100 g in 1 bottle, spray of Roycederm Stye Relief Eye Spray., a human over the counter drug labeled by Roycederm Llc. This spray is formulated for topical use and contains hypochlorous acid as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Roycederm Llc on August 12, 2025. The current certification is valid through December 31, 2026.

How is this Roycederm Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85424000601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85424-006-01
11-Digit CMS (5-4-2)
85424-0006-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.